India's Serum to double investment in Biocon's unit to $300 mln

Serum Institute of Life Sciences is a unit of Serum Institute of India, the world's biggest vaccine maker. Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/S35Mkve
via IFTTT